Search - tctmd.com

Displaying 421 - 440 of 568

Sort: Relevancy | Date

Presentation TCT 2015

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

Presenter: John R. Laird Jr, Gunnar Tepe, Marcus Thieme

October 12, 2015

Presentation TCT 2015

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: John R. Laird Jr, Gunnar Tepe, Gary M. Ansel

October 12, 2015

Presentation TCT 2015

DCB for Long and Highly Calcified Vessels: Is Upfront Vessel Preparation a Rational Choice?

Presenter: John R. Laird Jr, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Presenter: John R. Laird Jr, Gunnar Tepe, Thomas Zeller

October 12, 2015

Presentation TCT 2015

Complications of Coronary, Peripheral, and Structural Intervention

Presenter: Morton J. Kern, Mauricio G. Cohen

October 12, 2015

Presentation TCT 2015

The ILLUMINATE RCT: One-Year Outcomes

Presenter: William A. Gray, Peter A. Schneider, Mahmood K. Razavi

October 12, 2015

Presentation TCT 2015

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, Andrej Schmidt

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Optimizing Outcomes With DCB: Tips and Tricks

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation TCT 2015

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Presenter: Greg L. Kaluza, Thomas Zeller, Gunnar Tepe

October 12, 2015

Presentation TCT 2015

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Presenter: Greg L. Kaluza, Thomas Zeller

October 12, 2015

Presentation TCT 2015

Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Frequency and Approaches to Management

Presenter: Anthony J. Comerota, Mahmood K. Razavi, Matthew D. Bacchetta

October 11, 2015

Presentation TCT 2015

Acute PE Management in the Real World: Observations From a Successful Broad-Based Experience

Presenter: Anthony J. Comerota, Mahmood K. Razavi, Mark J. Goodwin

October 11, 2015

Presentation TCT 2015

Update on the Approach to DVT Management: When to Intervene and How?

Presenter: Anthony J. Comerota, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

Current State of Renal Stenting: Data and Indications for Intervention

Presenter: Anthony J. Comerota, Mahmood K. Razavi, Sahil A. Parikh

October 11, 2015

Presentation TCT 2015

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Presenter: J. A. Mustapha, Craig M. Walker, Andrej Schmidt

October 11, 2015

Presentation TCT 2015

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

Presenter: J. A. Mustapha, Craig M. Walker

October 11, 2015

Presentation TCT 2015

To Angiosome or Not to Angiosome? That Is the Question

Presenter: J. A. Mustapha, Craig M. Walker, Osamu Iida

October 11, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

Presentation TCT 2015

CTO PCI: An Australian Experience

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab, Ravinay Bhindi, James Sapontis

October 11, 2015

Advertisement

12 Month Outcomes From the Lutonix Global SFA Real-World Registry

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

DCB for Long and Highly Calcified Vessels: Is Upfront Vessel Preparation a Rational Choice?

DCB Treatment of In-Stent Restenosis With or Without Upfront Debulking: Updated Results

Complications of Coronary, Peripheral, and Structural Intervention

The ILLUMINATE RCT: One-Year Outcomes

Extended Follow-up From LEVANT 2: Two-Year Follow-up and Subgroup Analyses

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Optimizing Outcomes With DCB: Tips and Tricks

FIH Data Review Regarding Degree and Duration of DCB Efficacy in De Novo Lesions: Is There a Class Effect?

Technical Overview of FDA-Approved and CE-Marked DCB Technologies for PVD Intervention

Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Frequency and Approaches to Management

Acute PE Management in the Real World: Observations From a Successful Broad-Based Experience

Update on the Approach to DVT Management: When to Intervene and How?

Current State of Renal Stenting: Data and Indications for Intervention

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

To Angiosome or Not to Angiosome? That Is the Question

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

CTO PCI: An Australian Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content